Publications by authors named "Mathias Flume"

Claim this Profile
E
Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar/suprasellar tumors.
Julian Witte, Nicolas Touchot, Bastian Surmann, Kylie Braegelmann, Mathias Flume

Eur J Health Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of acquired hypothalamic obesity following traumatic brain injury and nonspecific hypothalamic microinjury: A nationwide German claims data analysis.
Julian Witte, Nicolas Touchot, Manuel Batram, Jana Diekmannshemke, Mathias Flume

J Neuroendocrinol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with tumor/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy.
Hermann L Müller, Julian Witte, Bastian Surmann, Manuel Batram, Kylie Braegelmann, Mathias Flume

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors-A German claims database analysis.
Julian Witte, Bastian Surmann, Manuel Batram, Markus Weinert, Mathias Flume

J Neuroendocrinol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham

J Mark Access Health Policy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVE.
Oriol de Solà-Morales, David Cunningham, Mathias Flume, Paul M Overton, Natalie Shalet

Int J Technol Assess Health Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical Hurdles in the Prioritization of Oncology Care.
Folkert de Groot, Stefano Capri, Jean-Claude Castanier, David Cunningham, Bruno Flamion, Mathias Flume

Appl Health Econ Health Policy· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Insights from Commercialization of Gene Therapies in Europe.
Nicolas Touchot, Mathias Flume

Genes (Basel)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and attractiveness of indication value-based pricing in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham

J Mark Access Health Policy· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The payers' perspective on gene therapies.
Nicolas Touchot, Mathias Flume

Nat Biotechnol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis